BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Integrated Proteins Ltd. Share Price

NSE
BSE

BSE : 519606

Sector : Trading

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 214.96 214.87
Expenses N/A N/A
PBT 3.2 2.74
Operating profit 0.0 0.0
Net profit 2.5 2.13

Shareholding Pattern

Promoters (% Holding)

2.23%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

97.77%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Integrated Proteins Ltd.

Founded 1992
Managing Director Karanj D Doshi

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Adani Enterprises Ltd. 3,95,441.46 3,026.50 1,753.00 - 1,753.00
Premier Energies Ltd. 49,004.07 1,079.50 660.00 - 660.00
Aditya Infotech Ltd. 42,886.38 3,639.05 0.00 - 0.00
Aegis Logistics Ltd. 35,394.84 1,006.95 576.10 - 576.10
Redington Ltd. 21,960.04 281.00 191.31 - 191.31
Honasa Consumer Ltd. 13,616.40 417.65 248.40 - 248.40
Lloyds Enterprises Ltd. 11,784.98 77.20 40.69 - 40.69
MMTC Ltd. 11,184.00 74.56 50.10 - 50.10
Cello World Ltd. 8,631.08 389.40 365.00 - 365.00
SG Mart Ltd. 7,539.43 597.20 313.10 - 313.10
no-content No Records Found

Latest News

Jun
18
2026
EQUITY Posted on Jun 18th 2026

Integrated Proteins informs about change in registered office address

Integrated Proteins has informed that the Board of Directors of the Company have considered and approved shifting of the Registered Office of the Company from 5 floor, City point, Opp Town Hall, Jamnagar, Gujarat, 361001 to Office No. 218, Manek Centre, Pandit Nehru Marg, Patel Colony, Jamnagar, Gujarat, 361008. However, due to an inadvertent clerical/administrative oversight, the intimation regarding the change in Registered Office could not be uploaded/submitted to the Stock Exchange within the prescribed timeline. The omission was purely unintentional and there was no deliberate attempt on the part of the Company to withhold any material information from the exchange or the stakeholders. Upon identification of the oversight, the Company has taken immediate steps to submit the requisite disclosure and ensure compliance with the applicable provisions. Further, the Company has strengthened its internal compliance review processes to avoid recurrence of such instances in future. 
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
19
2026
EQUITY Posted on Jun 19th 2026

Welcure Drugs & Pharmaceuticals informs about resignation CS cum CO

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations, 2015’), and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023, Welcure Drugs & Pharmaceuticals has informed that Palak Jain have tendered his resignation as a Company Secretary (CS), Compliance Officer (CO) and key managerial personnel of the Company with effect from close of business hours of June 19, 2026. The resignation letter received from Palak Jain is also enclosed. The Board of Directors of the Company has noted the same and placed on record its sincere appreciation for the contribution made by Palak Jain during his tenure as a Company Secretary, Compliance Officer and key managerial personnel with the Company. The relevant details as required under Regulation 30 read with Schedule III - Para A of Part A of the SEBI Listing Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated 13th July 2023, are given in Annexure A. 
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
19
2026
EQUITY Posted on Jun 19th 2026

Photoquip (India) informs about proceedings of AGM

Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Photoquip (India) has informed that it enclosed proceedings of the 34th Annual General Meeting of the Company held on Friday, 19th June, 2026 at 04th Floor, Royal Industrial Estate Co- Op. Society Naigaon Cross Road, Wadala, Mumbai, Maharashtra, India - 400031. The meeting commenced at 09:30 am and concluded at 10:00 am.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
19
2026
EQUITY Posted on Jun 19th 2026

Lloyds Enterprises informs about updates on acquisition of equity shares

Pursuant to Outcome of the meeting of the Board of Directors of the Company dated 18th June, 2026, Lloyds Enterprises has informed that the Company release its update on acquisition of Equity Shares of Steel Infra Solutions Company. In line with the above, it has attached additional details pertaining to the same. The same is also available on the Company’s website at www.lloydsenterprises.in.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
19
2026
EQUITY Posted on Jun 19th 2026

Evexia Lifecare informs about disclosure

Evexia Lifecare has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Kumar Jain M.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Integrated Proteins Ltd. ?

The current share price of Integrated Proteins Ltd. is ₹152.05 as of 2026-06-19.

The market capitalisation of Integrated Proteins Ltd. is ₹284.54 as of 2026-06-19.

The 1-year return of Integrated Proteins Ltd. is 108.55% as of 2026-06-19.

The P/E ratio of Integrated Proteins Ltd. is 50.87 as of 2026-06-20.

The 52-week high and low of Integrated Proteins Ltd. are ₹155.00 and ₹20.71, respectively, as of 2026-06-19.

The dividend yield of Integrated Proteins Ltd. is 0.0% as of2026-06-19.

You can buy Integrated Proteins Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Integrated Proteins Ltd. is Karanj D Doshi.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore